Details of the Drug

General Information of Drug (ID: DMXCJP8)

Drug Name
STP1002
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Drug Type
Small molecular drug
Cross-matching ID
PubChem CID
137017382
TTD ID
D5P3SI

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Tankyrase (TNKS) TTKSAQZ NOUNIPROTAC Inhibitor [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT04505839) First-In-Human Dose-Escalation Study of STP1002 in Patients With Advanced-Stage Solid Tumors. U.S. National Institutes of Health.
2 Design and development of a tankyrase inhibitor STP06-1002 as an anticancer therapeutic agent. Cancer Res 2017;77(13 Suppl):Abstract nr 5171.